Table 1.
Patient-Level Variable | Lung Cancer Screening |
Lung Nodule Program |
Non–Program Based |
p-Value |
---|---|---|---|---|
n = 111 | n = 357 | n = 1120 | ||
Age, n (%) | 0.0048 | |||
<49 | - | 6 (2) | 33 (3) | |
50–64 | 29 (26) | 84 (24) | 296 (26) | |
65–80 | 82 (74) | 234 (66) | 722 (64) | |
>80 | - | 33 (9) | 69 (6) | |
Mean (SD) | 68.4 (5.7) | 69.7 (9.1) | 68.4 (9) | 0.0205 |
Median (Q1, Q3) | 69 (64, 73) | 70 (64, 76) | 69 (63, 75) | |
Race, n (%) | 0.0905 | |||
White | 93 (84) | 274 (77) | 863 (77) | |
Black | 18 (16) | 71 (20) | 243 (22) | |
Other | - | 10 (3) | 12 (1) | |
Not reported | - | 2 (1) | 2 (0) | |
Sex, n (%) | 0.2347 | |||
Male | 51 (46) | 157 (44) | 549 (49) | |
Female | 60 (54) | 200 (56) | 571 (51) | |
Insurance, n (%) | 0.7819 | |||
Medicare | 52 (47) | 171 (48) | 541 (48) | |
Medicaid | 13 (12) | 45 (13) | 168 (15) | |
Commercial | 45 (41) | 135 (38) | 397 (35) | |
Self-Insured/None | 1 (1) | 6 (2) | 14 (1) | |
Smoking Status | <0.0001 | |||
Active | 67 (60) | 134 (38) | 453 (40) | |
Former | 44 (40) | 158 (44) | 516 (46) | |
Never | - | 65 (18) | 149 (13) | |
Not Reported | 2 (0) | |||
Charlson Comorbidity Score, n (%) | 0.0143 | |||
0 | 19 (17) | 102 (29) | 301 (27) | |
1 | 73 (66) | 174 (49) | 548 (49) | |
≥2 | 19 (17) | 81 (23) | 271 (24) | |
Co-morbidities | 0.292 | |||
Mean (SD) | 2.3 (1) | 2.2 (1.2) | 2.2 (1.2) | |
Median (Q1, Q3) | 2 (2, 3) | 2 (1, 3) | 2 (1, 3) |
SD, standard deviation; Q, quartile.